财务摘要（报告期）（Cyclacel Pharmaceuticals Inc Pfd）
| 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|
| 每股指标： | ||||||||
| 每股收益EPS基本(元) | -26.75 | -1.39 | -0.91 | -0.47 | -1.90 | -1.29 | -0.87 | -0.42 |
| 盈利能力： | ||||||||
| 销售毛利率(%) | 100.00 | 100.00 | 100.00 | - | - | - | - | - |
| 销售净利率(%) | -5,370.24 | -4,443.19 | -3,016.62 | - | - | - | - | - |
| 净资产收益率平均(%) | -214.40 | -139.78 | -74.86 | -33.09 | -74.03 | -43.18 | -25.74 | -11.63 |
| 总资产净利率(%) | -122.40 | -85.25 | -50.58 | -23.17 | -60.49 | -37.44 | -22.28 | -9.99 |
| 投入资本回报率ROIC(%) | -309.33 | -220.05 | -145.81 | -58.68 | -279.21 | -206.54 | -141.22 | -51.29 |
| 收益质量： | ||||||||
| 营业利润／利润总额(%) | 99.62 | 101.18 | 100.68 | 102.74 | 106.72 | 111.21 | 114.24 | 125.03 |
| 经营活动产生的现金流量净额／营业收入(%) | -3,836.19 | -3,136.76 | -2,189.28 | - | - | - | - | - |
| 资本结构： | ||||||||
| 资产负债率(%) | 93.11 | 65.62 | 41.43 | 33.63 | 27.26 | 14.38 | 14.54 | 15.69 |
| 权益乘数 | 14.51 | 2.91 | 1.71 | 1.51 | 1.37 | 1.17 | 1.17 | 1.19 |
| 产权比率 | 13.51 | 1.91 | 0.71 | 0.51 | 0.37 | 0.17 | 0.17 | 0.19 |
| 流动资产／总资产(%) | 84.54 | 88.93 | 93.02 | 86.01 | 88.76 | 89.99 | 90.75 | 92.30 |
| 非流动资产／总资产(%) | 15.46 | 11.07 | 6.98 | 13.99 | 11.24 | 10.01 | 9.25 | 7.70 |
| 流动负债／负债合计(%) | 99.55 | 99.37 | 99.03 | 98.92 | 98.59 | 97.60 | 97.80 | 99.76 |
| 非流动负债／负债合计(%) | 0.45 | 0.63 | 0.97 | 1.08 | 1.41 | 2.40 | 2.20 | 0.24 |
| 归属母公司股东的权益／投入资本(%) | 11.18 | 65.57 | 153.39 | 137.81 | 218.47 | 363.10 | 481.85 | 334.43 |
| 偿债能力： | ||||||||
| 流动比率 | 0.91 | 1.36 | 2.27 | 2.59 | 3.30 | 6.41 | 6.38 | 5.90 |
| 速动比率 | 0.91 | 1.36 | 2.27 | 2.59 | 3.30 | 6.41 | 6.38 | 5.90 |
| 货币资金／流动负债(%) | 41.39 | 72.95 | 150.67 | 155.83 | 248.17 | 544.59 | 578.53 | 477.74 |
| 营业利润／流动负债(%) | -311.89 | -246.60 | -196.38 | -99.74 | -374.13 | -432.14 | -245.60 | -105.72 |
| 经营活动产生的现金流量净额／流动负债(%) | -197.43 | -149.75 | -121.05 | -93.50 | -281.75 | -359.71 | -172.90 | -109.20 |
| 归属母公司股东的权益／负债合计(%) | 7.40 | 52.40 | 141.37 | 197.38 | 266.78 | 595.54 | 587.80 | 537.22 |
| 经营活动产生的现金流量净额／负债合计(%) | -196.54 | -148.80 | -119.88 | -92.49 | -277.77 | -351.08 | -169.10 | -108.94 |
| 营业利润／负债合计(%) | -310.48 | -245.04 | -194.48 | -98.67 | -368.85 | -421.77 | -240.20 | -105.47 |
| 成长能力： | ||||||||
| 总资产同比增长率(%) | -68.61 | -59.71 | -53.48 | -44.33 | -35.42 | -31.06 | -23.71 | -23.52 |
| 总负债同比增长率(%) | 7.63 | 83.86 | 32.55 | 19.28 | 40.83 | 22.70 | 64.82 | 65.05 |
| 基本每股收益同比增长率(%) | 6.79 | -6.92 | -4.60 | -11.90 | 11.21 | 19.38 | 18.69 | 16.00 |
| 归属母公司股东的权益同比增长率(%) | -97.03 | -83.82 | -68.12 | -56.17 | -46.32 | -35.79 | -30.10 | -30.47 |
| 营业利润同比增长率(%) | 7.97 | -6.82 | -7.32 | -11.59 | -20.57 | -14.67 | -18.64 | -52.36 |
| 股东权益合计同比增长率(%) | -97.03 | -83.82 | -68.12 | -56.17 | -46.32 | -35.79 | -30.10 | -30.47 |
| 营运能力： | ||||||||
| 流动资产周转率次(次) | 0.03 | 0.02 | 0.02 | - | - | - | - | - |
| 固定资产周转率次(次) | 20.49 | 16.21 | 13.32 | - | - | - | - | - |
| 总资产周转率次(次) | 0.02 | 0.02 | 0.02 | - | - | - | - | - |
| 衍生指标： | ||||||||
| 现金及现金等价物净增加额TTM(元) | -14,967,000.00 | -17,762,000.00 | -18,913,000.00 | -18,204,000.00 | -18,214,000.00 | -16,513,000.00 | -14,562,000.00 | -18,138,000.00 |
| 利润总额TTM(元) | -25,551,000.00 | -28,858,000.00 | -28,268,000.00 | -27,793,000.00 | -25,915,000.00 | -23,406,000.00 | -23,283,000.00 | -23,815,000.00 |
| 毛利TTM(元) | 420,000.00 | - | - | - | - | - | - | - |
| 投入资本(元) | 5,427,000.00 | 6,553,000.00 | 6,278,000.00 | 10,625,000.00 | 9,156,000.00 | 7,315,000.00 | 6,269,000.00 | 9,990,000.00 |
| 经营活动产生的现金流量净额TTM(元) | -16,112,000.00 | -17,371,000.00 | -20,303,000.00 | -20,913,000.00 | -20,827,000.00 | -20,207,000.00 | -19,449,000.00 | -21,749,000.00 |
| 总营业收入TTM(元) | 420,000.00 | - | - | - | - | - | - | - |
| 归属母公司净利润TTM(元) | -22,555,000.00 | -24,703,000.00 | -23,767,000.00 | -22,894,000.00 | -21,198,000.00 | -19,073,000.00 | -18,965,000.00 | -19,517,000.00 |
| 所得税TTM(元) | -2,996,000.00 | -4,155,000.00 | -4,501,000.00 | -4,899,000.00 | -4,717,000.00 | -4,333,000.00 | -4,318,000.00 | -4,298,000.00 |